Understanding the events and clinical aspects of a patient’s disease journey is fundamental to identifying key inflection points where new therapies and long-standing treatments can be applied to positively impact patient outcomes. This sample dataset provides a detailed view into the patient journey of Irritable Bowel Disease (IBD) patients in the United States. It is compiled from an extensive set of US healthcare claims data, and provides visibility into the drugs, diagnoses (comorbidities), and procedures of these patients, as well as the type of Health Care Providers the patients see. In addition, patient counts by US MSA (Metropolitan Statistical Area) are provided along with gender, age, and insurance distributions to support the depth of information supported by the underlying claims dataset.
Data Background:
• Source: US Claims Data, covering 280M patients
• Time Period: Patient Claims analyzed from 2015 to 2020
EVERSANA™ is the leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.
Usage Information
By subscribing to this product, you agree that your use of this product is subject to the provider's offer terms including pricing information and Data Subscription Agreement .
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing uses a single pricing dimension, Product Access (Units), offered at no cost. You get access to the product through this one option, so there are no tiers, instance sizes, or usage add-ons to compare. Pricing does not scale by consumption or commitment. The dimension simply grants subscribers entry to the patient journey analytics for irritable bowel disease. Because the product is free, you incur no charges tied to the number of units accessed.
Top-of-mind questions for buyers
What does one unit of Product Access grant me?
One unit grants a subscriber entry to the patient journey analytics for irritable bowel disease. It functions as an access grant rather than a metered resource. There are no compute sizes, seats, or data volumes tied to the unit. Access is provided at no charge.
Will my cost change as my usage or number of subscribers grows?
No. This dimension is offered at no cost and does not meter consumption or scale by commitment. Accessing more units or adding subscribers does not trigger charges. There are no tier boundaries, included amounts, or overage points that could change your bill.
Does the free access cover the wider analytics platform or just this dataset?
The Product Access unit grants entry to this patient journey analytics content for irritable bowel disease. Broader integrated patient analytics capabilities, data science services, and platform licenses are separate offerings from the vendor. For details on those, contact the vendor directly.
www.eversana.com
Helpful?
Vendor refund policy
Refunds are not available
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Accelerate your launch of the EVERSANA ORCHESTRATE™ Engine with Modus Create’s Implementation Accelerator—designed specifically for life sciences organizations seeking to scale omnichannel engagement. This 8 to 12-week engagement enables your team to quickly integrate the ORCHESTRATE platform within your AWS environment, leveraging pre-built connectors, FHIR-compliant pipelines, and secure, compliant infrastructure. Whether you’re standing up a pilot or scaling for enterprise use, this accelerator ensures a smooth path to value—built on deep domain expertise and AWS-native tools.